Nicoletta Cesari

发表

Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets

G. Floresta, C. Vergelli, M. Giovannoni, 2022, Structural Chemistry.

In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease

A. Maggi, P. Ciana, F. Blandini, 2018, Neurobiology of Disease.

6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.

J. Holderness, R. Ye, C. Vergelli, 2009, Journal of medicinal chemistry.

Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain.

C. Vergelli, M. Giovannoni, A. Cilibrizzi, 2009, Journal of medicinal chemistry.

Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors

V. D. Piaz, C. Vergelli, M. Giovannoni, 2007, Journal of enzyme inhibition and medicinal chemistry.

New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors.

C. Vergelli, M. Giovannoni, V. Dal Piaz, 2005, Bioorganic & medicinal chemistry letters.

Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action.

C. Ghelardini, N. Galeotti, C. Vergelli, 2006, Journal of medicinal chemistry.

4-Amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: Synthesis, SARs, and preliminary studies on the mechanism of action.

C. Vergelli, M. Giovannoni, V. Dal Piaz, 2007, Bioorganic & medicinal chemistry.

Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity.

P. Puccini, C. Vergelli, M. Giovannoni, 2010, Bioorganic & medicinal chemistry.

Synthesis and evaluation as PDE4 inhibitors of pyrimidine‐2,4‐dione derivatives

R. Matucci, C. Vergelli, M. Giovannoni, 2011 .

Local anti-inflammatory effect and behavioral studies on new PDE4 inhibitors.

V. Dal Piaz, S. Pieretti, A. Di Giannuario, 2006, Life sciences.

New Pyrazolo[1′,5′:1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as Potent and Selective PDE5 Inhibitors.

V. D. Piaz, C. Vergelli, M. Giovannoni, 2005 .

Endocrine influence on neuroinflammation: the use of reporter systems

A. Maggi, P. Ciana, N. Cesari, 2018, Journal of neuroendocrinology.

4-amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action.

C. Ghelardini, C. Vergelli, M. Giovannoni, 2007, Journal of medicinal chemistry.

Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity as potential agents for treatment of erectile dysfunction.

C. Vergelli, M. Giovannoni, A. Graziano, 2006, Journal of medicinal chemistry.